Nuvectis sinks after early-stage data for ovarian cancer therapy
Nuvectis Pharma (NVCT) stock falls as company posts interim data from a Phase 1b trial for its ovarian cancer drug candidate.
Nvidia tops list of favored S&P 500 stocks on expected sales growth through 2026
Investors are always hoping that companies will surprise analysts by showing higher profits than expected. These “earnings ...
Nvidia Is About To Beat Estimates Again
Nvidia's strong AI demand and Blackwell Superchips drive massive growth. Learn why NVDA stock is a Strong Buy with sustained ...
1 Wall Street Analyst Thinks Nvidia Stock Is Going to $178. Is It a Buy?
Redburn Atlantic analyst Timm Schulze-Melander initiated coverage of the stock this week with a "buy" rating. The analyst set ...
Nvidia Stock Investors Just Got Great News From Amazon and Google
Semiconductor company Nvidia (NASDAQ: NVDA) has seen its share price increase nearly 1,000% since the launch of ChatGPT in ...
Nvidia Stake Sends This AI Stock Higher Thursday
Shares of Applied Digital surged in extended trading Thursday after Nvidia reported a stake in the company. Nvidia held a roughly 3% stake in Applied Digital as of Sept. 30, according to a filing with ...
Nvidia's sky-high valuation raises red flags for veteran trader
Former Wall Street trader on whether or not Nvidia can continue its momentum in 2025.